Financial Summary (All financials)
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 270.3 | 189.2 | 116.3 | 90.0 |
| Revenue growth | 42.9% | 62.7% | 29.2% | |
| Cost of goods sold | 131.3 | 80.7 | 48.3 | 32.5 |
| Gross profit | 139.0 | 108.5 | 67.9 | 57.4 |
| Gross margin | 51.4% | 57.3% | 58.4% | 63.8% |
| Sales and marketing | 54.5 | 37.7 | 23.0 | 15.9 |
| Research and development | 21.2 | 13.1 | 7.8 | 3.5 |
| General and administrative | 68.2 | 45.3 | 22.5 | 17.4 |
| EBITA | -0.9 | 14.4 | 21.4 | 11.3 |
| EBITA margin | -0.3% | 7.6% | 18.4% | 12.5% |
| Amortization of intangibles | 34.2 | 22.7 | 14.4 | |
| EBIT | -35.1 | -8.3 | 7.0 | 11.3 |
| EBIT margin | -13.0% | -4.4% | 6.1% | 12.5% |
| Pre-tax income | -64.0 | -11.4 | -12.0 | 8.9 |
| Income taxes | -2.8 | 3.8 | 3.8 | -0.4 |
| Tax rate | 4.4% | | | |
| Net income | -61.2 | -15.4 | -15.7 | 6.5 |
| Net margin | -22.6% | -8.1% | -13.5% | 7.2% |
| |
| Diluted EPS | ($0.96) | ($0.28) | ($0.41) | $0.17 |
| Shares outstanding (diluted) | 63.9 | 55.9 | 37.9 | 37.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|